Sevoflurane Liquid
Product Images NDC 12164-005

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 12164-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Halocarbon Life Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sevoflurane 01)

Chemical structure of sevoflurane showing fluorinated carbon groups attached to a central carbon connected to an oxygen and fluoromethyl group.*

FDA Label Image

Figure 1 (Sevoflurane 02)

A line graph depicting the relationship between fresh gas flow rate (L/min) on the x-axis and concentration of compound A in ppm on the y-axis. The graph shows a decreasing trend in compound A concentration as the fresh gas flow rate increases from 0.5 to 3 L/min, leveling off between 3 and 4 L/min.*

FDA Label Image

Figure 2 (Sevoflurane 03)

A line graph depicting the relationship between carbon dioxide flow (in mL/min) and two variables: Compound A concentration (ppm) and maximum temperature (°C). The graph shows Compound A levels and maximum temperature increasing as carbon dioxide flow increases from 0 to 400 mL/min.*

FDA Label Image

Figure 2a (Sevoflurane 04)

A scatter plot graph showing the correlation between inspired compound AUC (ppm·hr) and Sevoflurane (MAC•Hour). Data points are plotted with a linear trend line illustrating a strong positive correlation (r = 0.96, p < 0.001) between the two variables.*

FDA Label Image

Figure 3 (Sevoflurane 05)

A line graph comparing the ratio of FA to FI (alveolar to inspired concentration) over time (minutes of administration) for five anesthetic agents: Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide (N2O). The x-axis represents minutes of administration up to 30 minutes, and the y-axis represents the FA/FI ratio ranging from 0 to 1.*

FDA Label Image

Figure 4 (Sevoflurane 06)

A pharmacokinetic elimination curve comparing concentrations of five anesthetic agents over time. The y-axis shows concentration ratio (FA/FAO) on a logarithmic scale, and the x-axis represents minutes of elimination up to 120. Agents plotted include Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide, showing their respective elimination profiles.*

FDA Label Image

Figure 5 (Sevoflurane 07)

A line graph depicting serum fluoride levels (µM) over days post-anesthesia for five different anesthetic agents: Methoxyflurane, Sevoflurane, Enflurane, Isoflurane, and Halothane. The x-axis represents days from pre-anesthesia to 6 days post-anesthesia, while the y-axis shows serum fluoride concentration in µM. Each agent has a distinct line with error bars indicating variability. Methoxyflurane shows the highest peak levels and a slow decline over days post-anesthesia, followed by Sevoflurane with moderate peak levels and decline, while Enflurane, Isoflurane, and Halothane remain low throughout.*

FDA Label Image

Figure 6 (Sevoflurane 08)

A line graph showing the concentration of sevoflurane over time in hours, with four lines representing mean concentration, mean concentration plus 1, 2, and 3 standard deviations. The y-axis is labeled 'Conc (µM)' and ranges from 0 to 70, while the x-axis ranges from 0 to 50 hours.*

FDA Label Image

Figure 7 (Sevoflurane 09)

A line graph showing heart rate in beats per minute on the vertical axis plotted against MAC level on the horizontal axis, comparing Sevoflurane with oxygen (Sevo/O2) versus Sevoflurane with oxygen and nitrous oxide (Sevo/O2/N2O). Data points with error bars illustrate changes from baseline through increasing MAC levels up to 2.0.*

FDA Label Image

Figure 8 (Sevoflurane 10)

A line graph comparing two groups labeled 'A - Sevo/O2' and 'C - Sevo/O2/N2O' with mmHg on the y-axis and MAC level on the x-axis. Data points show a decrease in mmHg from baseline through MAC levels 1 to 2. The graph includes error bars for each data point.*

FDA Label Image

Figure 9 (Sevoflurane 11)

A line graph plotting dyn·sec·cm⁻⁵ versus MAC level for Sevoflurane inhalation. It compares two conditions labeled as A (Sevoflurane/O₂) and C (Sevoflurane/O₂/N₂O) at baseline and increasing MAC levels from 1.0 to 2.0, showing a decreasing trend in values for both conditions.*

FDA Label Image

Figure 10 (Sevoflurane 12)

A line graph showing the relationship between MAC level (ranging from baseline to 2.5) on the x-axis and L/min/m² on the y-axis (ranging from 2 to 7). Two data series are plotted: 'A - Sevo/O2' represented by diamonds and 'C - Sevo/O2/N2O' represented by triangles, depicting ventilation rates at various MAC levels with error bars for variability.*

FDA Label Image

Principal Display Panel (250 mL Bottle Label)

Sevoflurane 1 mL/mL liquid inhalation anesthetic in a 250 mL container label. The label includes the NDC 12164-005-25, the indication as an inhalation anesthetic with Rx only, and states it is manufactured by Halocarbon Life Sciences, LLC in North Augusta, SC. Storage instructions and a barcode are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.